IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: A recent arrival from Mexico

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 6, 2008, Pages 2289-2290

  Martin, Craig A ^a   Morita, Kazumi ^a,c   Ribes, Julie A ^a   Deshpande, Lalitagauri M ^b   Sader, Helio S ^b   Castanheira, Mariana ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b JMI LABORATORIES   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; GENE STRUCTURE; HUMAN; LETTER; MALE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURGICAL INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HOSPITALS; HUMANS; IMIPENEM; KENTUCKY; MALE; MEXICO; PSEUDOMONAS AERUGINOSA; UNITED STATES;

EID: 44449119364     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00299-08     Document Type: Letter

References (7)

1. VIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC Program. J. Clin. Microbiol. 45:614-5.
2. Hanson, N. D., A. Hossain, L. Buck, E. S. Moland, and K. S. Thomson. 2006. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob. Agents Chemother. 50:2272-3.
3. Jones, R. N., C. Mendes, P. J. Turner, and R. Masterton. 2005. An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004. Diagn. Microbiol. Infect. Dis. 53:247-56.
4. Lolans, K., A. M. Queenan, K. Bush, A. Sahud, and J. P. Quinn. 2005. First nosocomial outbreak of Pseudomonas aeruginosa producing an integronborne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49:3538-40.
5. Sader, H. S., L. M. Deshpande, R. Morfin-Otero, U. Garza-Ramos, J. Silva- Sanchez, and R. N. Jones. 2007. Dissemination of IMP-type metallo-β-lactamases among Pseudomonas aeruginosa and emergence of VIM-2 in Klebsiella oxytoca in Mexico: report from the SENTRY Antimicrobial Surveillance Program, abstr. C2-2061, p. 150. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL.
6. VIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48:329-32.
7. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-25.